Home › Funds › Octagon Capital Advisors LP › TNGX
Octagon Capital Advisors LP position in TNGX
TANGO THERAPEUTICS INC · Health Care
Octagon Capital Advisors LP reported holding 630,000 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 2.09% of its reported portfolio and ranking #10 among its reported holdings. Octagon Capital Advisors LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's TNGX position evolved
Octagon Capital Advisors LP first disclosed a stake in TNGX in Q3 2026 at 630,000 shares (US$15.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 630.00K | $15.72M | New |
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 63 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$262.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- RTW INVESTMENTS, LP 14.05M sh · $350.51M · Q3 2026
- Boxer Capital Management, LLC 10.53M sh · $262.63M · Q3 2026
- Paradigm Biocapital Advisors LP 6.96M sh · $173.69M · Q3 2026
- Siren, L.L.C. 6.78M sh · $169.26M · Q3 2026
- TCG Crossover Management, LLC 6.77M sh · $168.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.18M sh · $129.24M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 4.55M sh · $113.54M · Q3 2026
- Deep Track Capital, LP 4.50M sh · $112.28M · Q3 2026
- PERCEPTIVE ADVISORS LLC 2.69M sh · $67.19M · Q3 2026
- Caligan Partners LP 2.50M sh · $62.41M · Q3 2026
- Seven Fleet Capital Management LP 2.23M sh · $55.71M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held TNGX?
Octagon Capital Advisors LP has disclosed TNGX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Octagon Capital Advisors LP's current position in TNGX?
As of Q3 2026, Octagon Capital Advisors LP holds 630.00K shares of TNGX (TANGO THERAPEUTICS INC), valued at $15.72M, representing 2.09% of its reported portfolio and ranking #10.
Has Octagon Capital Advisors LP been buying or selling TNGX?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP newly opened its position in TNGX.
Which other funds hold TNGX?
Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.